Effects of serum on in vitro susceptibility testing of echinocandins
- PMID: 17785512
- PMCID: PMC2151461
- DOI: 10.1128/AAC.01589-06
Effects of serum on in vitro susceptibility testing of echinocandins
Abstract
The effects of protein binding on the activities of caspofungin, anidulafungin, and micafungin were evaluated against Candida and Aspergillus species. Adding human serum sharply increased the MICs of micafungin and anidulafungin and modestly affected the MIC of caspofungin. The increase in MICs does not appear consistent with the rate of protein binding for the three compounds.
Similar articles
-
Influence of serum on in vitro susceptibility testing of echinocandins for Candida parapsilosis and Candida guilliermondii.Mycoses. 2012 Mar;55(2):156-60. doi: 10.1111/j.1439-0507.2011.02050.x. Epub 2011 Jun 12. Mycoses. 2012. PMID: 21668525
-
Evaluation of the Etest method for susceptibility testing of Aspergillus spp. and Fusarium spp. to three echinocandins.Med Mycol. 2010 Sep;48(6):858-61. doi: 10.3109/13693781003586943. Med Mycol. 2010. PMID: 20144131
-
The echinocandins.Pharmacotherapy. 2007 Mar;27(3):369-88. doi: 10.1592/phco.27.3.369. Pharmacotherapy. 2007. PMID: 17316149 Review.
-
Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit.Clin Microbiol Infect. 2009 Mar;15(3):274-9. doi: 10.1111/j.1469-0691.2008.02660.x. Epub 2009 Feb 5. Clin Microbiol Infect. 2009. PMID: 19210699
-
In vitro activity of echinocandins against non-Candida albicans: is echinocandin antifungal activity the same?Enferm Infecc Microbiol Clin. 2011 Mar;29 Suppl 2:3-9. doi: 10.1016/S0213-005X(11)70002-7. Enferm Infecc Microbiol Clin. 2011. PMID: 21420570 Review.
Cited by
-
PK/PD modeling and simulation of the in vitro activity of the combinations of isavuconazole with echinocandins against Candida auris.CPT Pharmacometrics Syst Pharmacol. 2023 Jun;12(6):770-782. doi: 10.1002/psp4.12949. Epub 2023 Mar 13. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 36915233 Free PMC article.
-
Echinocandin susceptibility testing of Candida spp. Using EUCAST EDef 7.1 and CLSI M27-A3 standard procedures: analysis of the influence of bovine serum albumin supplementation, storage time, and drug lots.Antimicrob Agents Chemother. 2011 Apr;55(4):1580-7. doi: 10.1128/AAC.01364-10. Epub 2011 Jan 18. Antimicrob Agents Chemother. 2011. PMID: 21245440 Free PMC article.
-
Drug susceptibility of matrix-encapsulated Candida albicans nano-biofilms.Biotechnol Bioeng. 2014 Feb;111(2):418-24. doi: 10.1002/bit.25120. Epub 2013 Oct 18. Biotechnol Bioeng. 2014. PMID: 24114441 Free PMC article.
-
Enfumafungin derivative MK-3118 shows increased in vitro potency against clinical echinocandin-resistant Candida Species and Aspergillus species isolates.Antimicrob Agents Chemother. 2014;58(2):1248-51. doi: 10.1128/AAC.02145-13. Epub 2013 Dec 9. Antimicrob Agents Chemother. 2014. PMID: 24323472 Free PMC article.
-
Anidulafungin and Micafungin Concentrations in Cerebrospinal Fluid and in Cerebral Cortex.Antimicrob Agents Chemother. 2020 Jun 23;64(7):e00275-20. doi: 10.1128/AAC.00275-20. Print 2020 Jun 23. Antimicrob Agents Chemother. 2020. PMID: 32340985 Free PMC article.
References
-
- Bartizal, K., C. J. Gill, G. K. Abruzzo, A. M. Flattery, L. Kong, P. M. Scott, J. G. Smith, C. E. Leighton, A. Bouffard, J. F. Dropinski, and J. Balkovec. 1997. In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872). Antimicrob. Agents Chemother. 41:2326-2332. - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources